医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Alcon Celebrates World Sight Day 2021 in Communities Worldwide with Programs for Improved Access to Eye Care

2021年10月14日 PM10:00
このエントリーをはてなブックマークに追加


 

GENEVA

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today celebrates World Sight Day 2021 by taking action in communities across the globe to raise awareness of blindness and vision impairment as global public health issues. Celebrated annually in October, World Sight Day is coordinated by the International Agency for the Prevention of Blindness (IAPB). This year’s theme, #LoveYourEyes, is all about being aware of your own eye health and the importance of regular, comprehensive eye exams for you and your loved ones.

As a steadfast advocate for eye health around the world, Alcon, through its two charitable foundations (Alcon Cares and Alcon Foundation), continues to provide support to people in communities around the world who are experiencing eye health issues including, cataracts, refractive errors, corneal blindness and more.

“Our eyes are one of our most important and intricate organs. Yet, they’re often not at the top of the list in terms of people’s healthcare priorities,” said David J. Endicott, Chief Executive Officer, Alcon. “Just imagine if one day you could no longer see your loved ones or participate in your favorite activities because of a preventable eye disease. Alcon is committed to educating people around the world about the importance of regular eye care as well as directly supporting access to eye care through the Alcon Foundation and Alcon Cares, in order to help people see brilliantly.”

Alcon and its associates are further recognizing World Sight Day by supporting and participating in initiatives that promote eye health awareness and quality eye care worldwide, such as:

  • EYElliance, a multi-sector coalition that aims to increase access to eyeglasses at scale, and its National Eye Health Initiative in Liberia is hosting a webinar moderated by Alcon U.S. Vision Care General Manager Sean Clark for Alcon associates worldwide, discussing the organization’s progress and learnings in the country, as well as plans to expand its impact by partnering with the Clinton Health Access Initiative.
  • The Steps for Sight Challenge invites 2,020 Alcon associates from across the globe to take 5,000 steps on World Sight Day to raise a total of $25,000 for eye care organizations, including Orbis and VisionSpring.
  • Alcon Geneva associates will focus the day on learning more about eye health, including onsite vision screenings with one of Alcon’s in-house Swiss-registered optometrists. They will also participate in learning sessions about Alcon’s sight-enhancing surgical equipment and vision care products.
  • Alcon’s Children’s Vision Program, where Alcon associates and partners are delivering free, custom prescription eyeglasses to nearly 200 Texas students who participated in recent vision care screenings and exams hosted at school as part of this year’s program.
  • Alcon the Fireworks was held on the evening of October 10 in Inzai City, Chiba Prefecture, in honor of Japan Sight Day. The fireworks event was held to educate people about the “20-20-20 rule” (look at least 20 feet away for at least 20 seconds every 20 minutes when using a digital device).*1 While digital devices and digital content have enriched our lives, there are concerns about the impact of prolonged use of digital devices on eye health, including eye strain and myopia. It is recommended that we all follow the “20-20-20 rule” when using digital devices.*1

Beyond World Sight Day, Alcon helps people around the world see brilliantly through its corporate giving efforts, such as the Alcon Foundation and Alcon Cares programs. Additional programs include:

  • Continued partnership with Fort Worth Independent School District with the Children’s Vision Program to provide students from low-income families with vital eye care services, including screenings, exams and eyeglasses.
  • Participation with VisionSpring in India to provide low-income families with accessible, affordable and culturally appropriate optical services to enable them to return to work, receive an education and live safer, longer lives.
  • Partnership with Kentucky College of Optometry to deliver eye care services to impoverished communities within the U.S. where there are high rates of vision loss due to lack of access to eye care services.
  • Long-time partnership with Mercy Ships, providing patients in sub-Saharan Africa who have limited-to-no access to healthcare with quality eye care services.
  • Virtual and hands-on learning and mentoring with Orbis, an international non-profit aimed at fighting blindness, to train teams of eye care professionals in communities with the greatest need to help save people’s sight.

For more information on Alcon’s commitment to expanding global eye care access during World Sight Day and beyond visit alcon.com/about-us/corporate-social-responsibility.

Cautionary Note Regarding Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “commitment,” “look forward,” “maintain,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “will” and similar references to future periods.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties and risks that are difficult to predict. Some of these factors are discussed in our filings with the United States Securities and Exchange Commission, including our Form 20-F. In particular, our expectations could be affected by uncertainties regarding the success of our separation and spin-off from Novartis. Should one or more of these uncertainties or risks materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated. Therefore, you should not rely on any of these forward-looking statements.

Forward-looking statements in this press release speak only as of the date of its filing, and we assume no obligation to update forward-looking statements as a result of new information, future events or otherwise.

References
   *1 American Academy of Ophthalmology (American Academy of Ophthalmology)
   https://www.aao.org/eye-health/tips-prevention/computer-usage

About Alcon
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 23,000 associates are enhancing the quality of life through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.

Alcon Foundation
For more than 50 years, Alcon has partnered with non-profit organizations that help advance eye health, skills transfer, education and access to quality eye care around the world. The Alcon Foundation awards grants to qualified, U.S.-based tax-exempt public 501(c)(3) charities that provide high-quality programs, training and community services with well-defined goals to enhance sight and improve the lives of people who otherwise would not have access to proper eye care. For more information, visit https://www.alcon.com/about-us/corporate-responsibility/eye-care-everyone.

Connect with us on
Facebook
LinkedIn

View source version on businesswire.com: https://www.businesswire.com/news/home/20211014005225/en/

CONTACT

Investor Relations

Allen Trang

+ 41 589 112 110 (Geneva)

+ 1 817 615 2789 (Fort Worth)

investor.relations@alcon.com

Media Relations

Steven Smith

+ 41 589 112 111 (Geneva)

+ 1 817 551 8057 (Fort Worth)

globalmedia.relations@alcon.com

同じカテゴリーの記事 

  • La Jolla Institute for Immunology and RevolKa started a Research Collaboration
  • U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表